Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients Aged 65 Years or Older With Chronic Hepatitis C: A Pooled Analysis of Phase 2 and 3 Clinical Trials

被引：0
|
作者：
Foster, Graham R. [1 ]
Kopecky-Bromberg, Sarah [2 ]
Lei, Yang [2 ]
Mensa, Federico J. [2 ]
机构：
[1] Queen Mary Univ London, Hepatol Unit, London, England
[2] AbbVie Inc, N Chicago, IL USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1188
引用
收藏
页码：640A / 641A
页数：2
相关论文
共 50 条
  • [11] Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study
    Pugliese, Nicola
    Calvaruso, Vincenza
    Masarone, Mario
    D'Ambrosio, Roberta
    Battistella, Sara
    Licata, Anna
    Persico, Marcello
    Anolli, Maria Paola
    Distefano, Marco
    Petta, Salvatore
    Russo, Francesco Paolo
    Di Marco, Vito
    Aghemo, Alessio
    LIVER INTERNATIONAL, 2023, 43 (07) : 1440 - 1445
  • [12] Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
    Toyoda, Hidenori
    Chayama, Kazuaki
    Suzuki, Fumitaka
    Sato, Ken
    Atarashi, Tomofumi
    Watanabe, Tsunamasa
    Atsukawa, Masanori
    Naganuma, Atsushi
    Notsumata, Kazuo
    Osaki, Yukio
    Nakamuta, Makoto
    Takaguchi, Koichi
    Saito, Satoru
    Kato, Koji
    Pugatch, David
    Burroughs, Margaret
    Redman, Rebecca
    Alves, Katia
    Pilot-Matias, Tami J.
    Oberoi, Rajneet K.
    Fu, Bo
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 67 (02) : 505 - 513
  • [13] TREATMENT WITH GLECAPREVIR AND PIBRENTASVIR IS SAFE AND EFFECTIVE IN ITALIAN PATIENTS WITH CHRONIC HEPATITIS C AGED 75 YEARS OR OLDER: A MULTICENTER STUDY
    Pugliese, Nicola
    Calvaruso, Vincenza
    Masarone, Mario
    D'Ambrosio, Roberta
    Battistella, Sara
    Licata, Anna
    Persico, Marcello
    Anolli, Maria Paola
    Russo, Francesco Paolo
    Distefano, Marco
    Petta, Salvatore
    Di Marco, Vito
    Aghemo, Alessio
    HEPATOLOGY, 2023, 77 (05) : E171 - E171
  • [14] Efficacy and safety of glecaprevir/pibrentasvir treatment in Koreans with chronic hepatitis C: A retrospective study
    Kwan, Byung Soo
    Kong, Sung Min
    Shim, Sang Goon
    Kim, Kwang Min
    Yu, Gil Jong
    Lee, Jae Jin
    Kim, Jin Dong
    ARAB JOURNAL OF GASTROENTEROLOGY, 2023, 24 (02) : 104 - 108
  • [15] Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Patients Aged 65 Years or Older: A Retrospective Analysis of Phase 3
    Saab, Sammy
    Mizokami, Masashi
    Omata, Masao
    Mangia, Alessandra
    Eggleton, Ed
    Seyedkazemi, Star
    Zhu, Yanni
    Knox, Steven J.
    Pang, Phil
    Subramanian, G. M.
    Kowdley, Kris
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2015, 148 (04) : S1085 - S1085
  • [16] SAFETY AND EFFICACY OF STATIN MANAGEMENT DURING GLECAPREVIR/PIBRENTASVIR TREATMENT FOR CHRONIC HEPATITIS C
    Kwo, Paul
    Jones, Peter
    Barcomb, Lisa
    Gathe, Joseph, Jr.
    Yu, Yao
    Dylla, Douglas
    Porcalla, Ariel
    Mensa, Federico
    Toth, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1763 - 1763
  • [17] Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection with and without cirrhosis
    Chayama, K.
    Suzuki, F.
    Sato, K.
    Atarashi, T.
    Watanabe, T.
    Toyoda, H.
    Atsukawa, M.
    Naganuma, A.
    Notsumata, K.
    Osaki, Y.
    Nakamuta, M.
    Takaguchi, K.
    Saito, S.
    Kato, K.
    Pugatch, D. L.
    Burroughs, M.
    Redman, R.
    Alves, K.
    Pilot-Matias, T.
    Fu, B.
    Kumada, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S528 - S528
  • [18] Real-Life Efficacy and Safety of Glecaprevir/Pibrentasvir Pediatric Formulation for Chronic Hepatitis C Infection in Children Aged 3 to 12 Years: A Case Series of 6 Patients
    Musto, Francesca
    Stracuzzi, Marta
    Cibarelli, Alessandro
    Coppola, Crescenzo
    Caiazzo, Roberta
    David, Daniela
    Di Tonno, Raffaella
    Garcia, Marc Lorenzo
    Valentino, Maria Sole
    Giacomet, Vania
    CLINICAL THERAPEUTICS, 2025, 47 (03) : 244 - 247
  • [19] Pooled resistance analysis in HCV genotype 1-6-infected patients treated with glecaprevir/pibrentasvir in phase 2 and 3 clinical trials
    Krishnan, P.
    Schnell, G.
    Tripathi, R.
    Ng, T.
    Reisch, T.
    Beyer, J.
    Dekhtyar, T.
    Irvin, M.
    Xie, W.
    Larsen, L.
    Mensa, F.
    Pilot-Matias, T.
    Collins, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S500 - S500
  • [20] Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Infected with HCV GT1-3 by Renal Impairment Status: A Pooled Analysis of Two Phase 3 Japanese Trials
    Atsukawa, Masanori
    Chayama, Kazuaki
    Suzuki, Fumitaka
    Sato, Ken
    Karino, Yoshiyasu
    Atarashi, Tomofumi
    Kawakami, Yoshiiku
    Naganuma, Atsushi
    Pugatch, David
    Alves, Katia
    Kato, Koji
    Redman, Rebecca
    Burroughs, Margaret
    Abunimeh, Manal
    Xie, Wangang
    Kumada, Hiromitsu
    HEPATOLOGY, 2017, 66 : 634A - 635A
12345